A common insulin pen slips into shortage

A widely used insulin pen product has entered shortage as other pen options leave the market, complicating access to a basic medicine.

According to STAT, a popular insulin pen product has entered a shortage at the same time that other pen options are being pulled from the market. For people managing diabetes, that combination narrows the choices available at the pharmacy counter and can force a scramble to find a working equivalent.

Insulin is not an optional medicine. When a familiar product disappears, patients face switching formulations or delivery devices, which can mean new prescriptions, new dosing routines, and time lost tracking down supply. Each of those steps is a point where access can break down.

This is a setback for a need that should be moving toward reliability, not away from it. We are working only from the metadata line here; the source is a paywalled STAT+ report and the specific products, timelines, and scale of the shortage sit with their reporting.

Source: STAT